Michael F. Mahoney - Feb 15, 2023 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role: Chairman, President & CEO, Director
Signature: /s/ Susan Thompson, Attorney-in-Fact
Stock symbol: BSX
Transactions as of: Feb 15, 2023
Transactions value $: -$387,116
Form type: 4
Date filed: 2/16/2023, 06:17 PM
Previous filing: Feb 15, 2023
Next filing: Feb 21, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BSX	Common Stock	Options Exercise	$0	+18.5K	+1.02%	$0.00	1.82M	Feb 15, 2023	Direct	F1
transaction	BSX	Common Stock	Tax liability	-$387K	-8.19K	-0.45%	$47.29	1.81M	Feb 15, 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BSX	Deferred Stock Units	Options Exercise	$0	-18.5K	-100%	$0.00^*	0	Feb 15, 2023	Common Stock	18.5K		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2	Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant.